Guardion Health Sciences, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 11.91 million compared to USD 10.64 million a year ago. Revenue was USD 12.25 million compared to USD 11.05 million a year ago.

Net income was USD 0.158033 million compared to net loss of USD 14.92 million a year ago. Basic earnings per share from continuing operations was USD 0.12 compared to basic loss per share from continuing operations of USD 14.15 a year ago.